EN

EnteroBiotix

Glasgow · 1 known investors

enterobiotix.com ↗

EnteroBiotix is a clinical-stage microbiome therapeutics company developing EBX-102-02, an orally delivered, full-spectrum microbiome drug for irritable bowel syndrome and other gastrointestinal and liver diseases. It uses proprietary AMPLA drying technology and MHRA-licensed GMP manufacturing, with a pipeline spanning IBS, liver cirrhosis, and adjuvant treatment in blood cancer.</parameter> <parameter name="founders">[]

Investors · 1

SC

Scottish National Investment BankEdinburgh · $1.3M

Competitors · 3

by search overlap

PA

PatSnap7 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

DI

Diabetes Prevention Program6 shared keywords

NA

Nanobiotix5 shared keywordsNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.

Companies competing with EnteroBiotix for the same Google search keywords, organic and paid, via search-intersection analysis.